West Africa, East Africa, Southern Africa, Western Europe, the Middle East and South East Asia. March 20, 2018 – Evolva posted its financial results for the period from 1 January to 31 December 2017, and urban forex support and resistance software business highlights that illustrate how the Company is executing on its strategic transformation plan which was put in place last August.
Nootkatone pest control products – Evolva has filed for US EPA registration for the active ingredient nootkatone, a process that is expected to be completed by the end of 2018. In parallel, Evolva is actively engaged in discussions with leading pest control product companies to supply nootkatone for next-generation tick and mosquito products. Resveratrol products – Following on the heels of the launch of our Veri-teTM brand, revenue growth is accelerating. Symrise may be interested in the acquisition of Frutarom. Swiss francs compared to the previous year. Philippe Maubert and examined the Group’s activity and its results. Europe, and in Asia, according to the Group’s objectives.
Consolidated net profit, unaudited, is in the order of 48. Final results will be published by April 25, 2018. Frutarom Full Year 2017 Sales – March 20, 2018 – In 2017 Sales grew by 18. 4 million, constant currency pro forma growth of 6.
Sales from Core Activities grew by 19. 4 million, constant currency pro forma growth of 7. Sales from Flavors activity grew by 21. Sales from Natural Specialty Fine Ingredients grew by 14. 1 million, constant currency pro forma growth of 11.
Adjusted for nonrecurring expenses3 the EBITDA grew by 23. A record cash flow from operations grew by 50. Earnings per share grew by 36. Frutarom Expects 2018 to be Yet Another Record Year, as it Continues to Improve its Profitability, also through Projects for Combining Plants and Resource Optimization, and the Successful Completion of the Enzymotec Acquisition.